These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17955504)

  • 1. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF.
    Woodward RM; Brown ML; Stewart ST; Cronin KA; Cutler DM
    Cancer; 2007 Dec; 110(11):2511-8. PubMed ID: 17955504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
    Ramsey SD; Howlader N; Etzioni RD; Donato B
    J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness and lung cancer clinical trials.
    Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
    Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of medical spending in the United States, 1960-2000.
    Cutler DM; Rosen AB; Vijan S
    N Engl J Med; 2006 Aug; 355(9):920-7. PubMed ID: 16943404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of new chemotherapeutic agents for metastatic colorectal cancer.
    Howard DH; Kauh J; Lipscomb J
    Arch Intern Med; 2010 Mar; 170(6):537-42. PubMed ID: 20233802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
    Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
    Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
    Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
    Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic non-small cell lung cancer: costs associated with disease progression.
    Fox KM; Brooks JM; Kim J
    Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K; Bonomi M; Packer S; Wisnivesky J
    Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical model of cost of bladder cancer in the elderly.
    Cooksley CD; Avritscher EB; Grossman HB; Sabichi AL; Dinney CP; Pettaway C; Elting LS
    Urology; 2008 Mar; 71(3):519-25. PubMed ID: 18342201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
    Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
    Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.